Ligandal

company

About

Ligandal is creating delivery systems and AI-driven targeting approaches for cell-specific and precision genetic medicine.

  • Brooklyn,New York,United States
  • 1 - 10

Details

Last Funding Type
Seed
Industries
Biotechnology,Genetics,Nanotechnology
Founded date
Jan 1, 2014
Number Of Employee
1 - 10
Operating Status
Active
Legal Name
Ligandal Inc.

Ligandal's mission is to create precision delivery platform to cure and treat disease. We are driving the discovery and delivery of a broad array of gene therapies, genetic materials, and gene-specific payloads with unprecedented precision at the cellular and sub-cellular level. Our ligand discovery engine allows for rapid design of diagnostically-responsive materials, capable of shuttling a variety of nucleic acid and protein payloads (including CRISPR and mRNA) to specific cell types. We are initially applying this technology to indications in hematology, immuno-oncology, and infectious disease.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
7
$4.64M
Ligandal has raised a total of $4.64M in funding over 2 rounds. Their latest funding was raised on Feb 1, 2019 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 1, 2019 Seed $1.80M — — — Detail
Oct 24, 2017 Seed — 1 — — Detail
Oct 1, 2017 Seed $2M 2 — — Detail
Aug 9, 2016 Angel $330K 10 — — Detail
Aug 6, 2015 Angel $200K 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
20
Ligandal is funded by 20 investors. Bioverge and Social Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Bioverge — Seed
Social Capital — Seed
Social Impact Capital — Seed
D.A. Wallach — Angel
Eric Anschutz — Angel
Esther Dyson — Angel
Jeff Hammerbacher — Angel
Jeremy Yap — Angel
Justin Rosenstein — Angel
Kauffman Fellows — Angel

Employee Profiles

Number of Employee Profiles
3
Ligandal has 3 current employee profiles, including Executive Andre Watson
Executive
Executive
Executive